Yuying Huo

Ms. Yuying Huo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2023 in Journal of Genetics and Genomics
Verified
Journal Article
Closed access
YHYuying Huo
Yuying Huo
YGYilang Guo
Yilang Guo
JWJiakang Wang
Jiakang Wang
HXHuijie Xue
Huijie Xue
YFYujuan Feng
Yujuan Feng
XLXiangyu Li
Xiangyu Li

13 September 2024 in Journal of Genetics and Genomics
Verified
Journal Article
Closed access
YHYuying Huo
Yuying Huo
JWJiakang Wang
Jiakang Wang
CLChengcheng Liu
Chengcheng Liu
JWJinxia Wang
Jinxia Wang
CWChen Wang
Chen Wang
XLXiangyu Li
Xiangyu Li

5 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
CLChengcheng Liu
Chengcheng Liu
YHYuying Huo
Yuying Huo
YZYansong Zhang
Yansong Zhang
FYFumei Yin
Fumei Yin
TCTaoyu Chen
Taoyu Chen
MZMichael Q. Zhang
Michael Q. Zhang
Background: Gastric cancer is a malignant tumor with high morbidity and mortality. Therefore, the accurate recognition of prognostic molecular markers is the key to improving treatment efficacy and prognosis. Methods: In this study, we developed a stable and robust signature through a series of processes using machine-learning approaches. This PRGS was further experimentally validated in clinical samples and a gastric cancer cell line. Results: The PRGS is an independent risk factor for overall survival that performs reliably and has a robust utility. Notably, PRGS proteins promote cancer cell proliferation by regulating the cell cycle. Besides, the high-risk group displayed a lower tumor purity, higher immune cell infiltration, and lower oncogenic mutation than the low-PRGS group. Conclusions: This PRGS could be a powerful and robust tool to improve clinical outcomes for individual gastric cancer patients.